查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1803020

全球 SPECT 扫描服务市场：预测至 2032 年 - 按产品类型、放射性同位素类型、应用、最终用户和地区进行分析

SPECT Scanning Services Market Forecasts to 2032 - Global Analysis By Product Type, Radioisotope Type (Technetium-99m, Gallium-67, Iodine-123, Thallium-201, Radium-223 and Other Radioisotope Types), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球 SPECT 扫描服务市场预计在 2025 年达到 27.5 亿美元，到 2032 年将达到 54.7 亿美元，预测期内的复合年增长率为 10.3%。

SPECT扫描服务利用单光子发射电脑断层扫描（SEP）技术，透过侦测放射性示踪剂发射的伽玛射线，创造内臟器官和组织的详细3D影像。这些服务透过评估血流、代谢活动和受体结合情况，支持神经系统、心臟和肿瘤疾病的诊断评估。此操作为非侵入式，通常在专门的影像中心进行。核子医学专家的精准判读有助于早期发现疾病、制定治疗计划并监测治疗效果，从而改善临床决策和患者预后。

根据《EJNMMI Physics》报道，SPECT 影像已成为核子医学应用的基石，全球超过 70% 的核子医学部门整合了 SPECT 或 SPECT/CT 系统，用于心臟病学、神经病学和肿瘤学的常规诊断和治疗计划。

心血管、肿瘤、神经和代谢疾病发生率上升

随着这些慢性疾病在人群中日益普遍，医疗保健提供者越来越依赖先进的影像技术进行早期发现和精准监测。此外，SPECT 技术效率和准确性的不断提升也推动了其在临床上的应用，并改善了患者的预后。个人化医疗日益受到重视，这进一步推动了 SPECT 检测的使用，使其能够根据患者的个别情况量身定制治疗方案。

来自PET和其他治疗方式的竞争压力

PET 尤其成为肿瘤学和神经病学领域的首选，因为它具有卓越的空间解析度和定量分析能力。此外，PET/CT 和 PET/MRI 等混合影像系统也因其能够整合解剖和功能资料而日益普及。这种竞争格局要求 SPECT服务供应商不断创新，提升影像品质、工作流程效率和示踪剂特异性，才能在快速发展的诊断生态系统中保持竞争力。

与人工智慧（AI）和机器学习的集成

人工智慧和机器学习与 SPECT 影像工作流程的整合，为市场成长带来了变革性机会。这些技术正被用于增强影像重建、自动化异常检测和优化扫描通讯协定，从而提高诊断准确性和业务效率。主导的分析也有助于预测建模和个人化治疗计划，从而提升 SPECT 在精准医疗中的价值。

依赖训练有素的核子医学和放射学专业人员

准确解读 SPECT 扫描结果需要大量的核子医学和放射学培训，这限制了在劳动力短缺地区开展服务的扩充性。此外，放射性药物的处理和合规性非常复杂，需要严格的监管，并可能造成营运资源紧张。如果教育和培训投入不足，合格专业人员的缺乏可能会阻碍服务扩展，并延迟在服务匮乏地区的推广。

COVID-19的影响：

新冠疫情对 SPECT 扫描服务市场产生了多方面的影响。起初，由于封锁和感染控制措施，选择性影像检查被推迟，患者数量也随之减少。然而，这场危机也凸显了影像学在管理与病毒相关的心血管和肺部併发症的重要性。随着医疗系统适应疫情，SPECT 服务的优先顺序被重新调整，用于重症加护和新冠疫情后评估。

预计 SPECT 扫描设备市场在预测期内将占据最大份额

由于 SPECT 扫描设备在临床上的广泛应用和技术进步，预计将在预测期内占据最大的市场占有率。这些系统越来越多地配备了多检测器配置和数位处理功能，从而提高了影像解析度和吞吐量。它们能够诊断从心臟缺血到神经退化性疾病等一系列疾病，使其成为功能性影像诊断的基石。

冠状动脉疾病诊断领域预计将在预测期内实现最高复合年增长率

冠状动脉疾病诊断领域预计将在预测期内实现最高成长率，这得益于全球心血管疾病负担的不断增加。 SPECT心肌灌注显像是一种成熟的技术，可用于评估血流和侦测缺血区域，为了解心臟功能提供重要依据。放射性示踪剂和影像通讯协定的创新正在提高诊断准确性和病患安全性。随着预防心臟病学的发展势头强劲，SPECT在风险分层和治疗效果监测方面发挥关键作用，尤其是在高风险族群中。

占比最高的地区：

预计北美将在预测期内占据最大的市场占有率，这得益于其先进的医疗基础设施和核医学成像技术的广泛应用。该地区拥有许多优势，例如强大的报销框架、主要成像设备製造商的布局以及训练有素的专业人员的广泛供应。此外，正在进行的研究倡议和临床试验正在推动放射性药物和成像通讯协定的创新。

复合年增长率最高的地区：

预计北美将在预测期内实现最高的复合年增长率，这得益于医疗基础设施的扩张、人们对先进影像诊断技术的认识不断提高，以及中国和印度等新兴经济体心血管和神经系统疾病等慢性病患病率的上升。此外，政府旨在改善医疗服务可近性的措施、增加医疗技术投入以及可支配收入的提高，正在刺激 SPECT 扫描服务的普及。

免费客製化服务

此报告的订阅者可以从以下免费自订选项中选择一项：

  • 公司简介
    • 对最多三家其他公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 简介

  • 概述
  • 相关利益者
  • 分析范围
  • 分析方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 分析方法
  • 分析材料
    • 主要研究资料
    • 二手研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 市场机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代产品的威胁
  • 新参与企业的威胁
  • 企业之间的竞争

5. 全球 SPECT 扫描服务市场（依产品类型）

  • SPECT扫描设备
    • 可携式SPECT 系统
    • 固定/独立 SPECT 系统
    • SPECT/CT混合系统
  • SPECT扫描服务
    • 诊断影像
    • 治疗监测
    • 药物开发和研究支持

6. 全球 SPECT 扫描服务市场（依放射性同位素类型）

  • Technetium-99m（Tc-99m）
  • 镓-67（Ga-67）
  • 碘-123（I-123）
  • 铊-201（Th-201）
  • 镭-223（Ra-223）
  • 其他类型的放射性同位素

7. 全球 SPECT 扫描服务市场（按应用）

  • 心肌灌注显像
  • 冠状动脉疾病的诊断
  • 肿瘤检测与监测
  • 癌症分期
  • 脑损伤
  • 癫痫诊断
  • 其他用途

8. 全球 SPECT 扫描服务市场（按最终用户）

  • 诊断影像中心
  • 医院
  • 门诊手术中心（ASC）
  • 研究和学术机构
  • 其他最终用户

9. 全球 SPECT 扫描服务市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：主要趋势

  • 合约、商业伙伴关係和合资企业
  • 企业合併与收购（M&A）
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Bracco Imaging
  • Curium Pharma
  • Cardinal Health Inc.
  • Lantheus Medical Imaging
  • Digirad Corporation
  • Spectrum Dynamics Medical
  • Gamma Medica Inc.
  • Guerbet
  • Neusoft Medical Systems
  • Toshiba International Corporation
  • Mediso Ltd.
  • Positron Corporation
Product Code: SMRC30546

According to Stratistics MRC, the Global SPECT Scanning Services Market is accounted for $2.75 billion in 2025 and is expected to reach $5.47 billion by 2032 growing at a CAGR of 10.3% during the forecast period. SPECT scanning services utilize Single Photon Emission Computed Tomography to produce detailed 3D images of internal organs and tissues by detecting gamma rays emitted from radiotracers. These services support diagnostic evaluation of neurological, cardiac, and oncological conditions by assessing blood flow, metabolic activity, and receptor binding. Procedures are non-invasive and typically conducted in specialized imaging centers. Accurate interpretation by nuclear medicine professionals enables early disease detection, treatment planning, and monitoring of therapeutic response, enhancing clinical decision-making and patient care outcomes.

According to EJNMMI Physics, SPECT imaging has become a cornerstone in theranostic applications, with over 70% of nuclear medicine department's worldwide integrating SPECT or SPECT/CT systems for routine diagnostic and therapeutic planning in cardiology, neurology, and oncology.

Market Dynamics:

Driver:

Increased rates of cardiovascular, oncological, neurological, and metabolic disorders

As these chronic diseases become more prevalent across demographics, healthcare providers increasingly rely on advanced diagnostic imaging to enable early detection and accurate monitoring. Additionally, improvements in the efficiency and precision of SPECT technology are encouraging wider clinical adoption, supporting better patient outcomes. The growing emphasis on personalized medicine further drives the use of SPECT scans to tailor treatments based on individual patient profiles.

Restraint:

Competitive pressure from PET and other modalities

PET, in particular, offers superior spatial resolution and quantitative capabilities, making it the preferred choice in oncology and neurology. Additionally, hybrid imaging systems like PET/CT and PET/MRI are gaining traction due to their ability to combine anatomical and functional data. This competitive landscape is challenging SPECT service providers to innovate and improve image quality, workflow efficiency, and tracer specificity to maintain relevance in a rapidly evolving diagnostic ecosystem.

Opportunity:

Integration with artificial intelligence (AI) and machine learning

The integration of AI and machine learning into SPECT imaging workflows presents a transformative opportunity for market growth. These technologies are being leveraged to enhance image reconstruction, automate anomaly detection, and optimize scan protocols, thereby improving diagnostic accuracy and operational efficiency. AI-driven analytics can also assist in predictive modeling and personalized treatment planning, making SPECT more valuable in precision medicine.

Threat:

Reliance on highly trained nuclear medicine and radiology professionals

Accurate interpretation of SPECT scans requires extensive training in nuclear medicine and radiology, limiting the scalability of services in regions with workforce shortages. Additionally, the complexity of radiopharmaceutical handling and regulatory compliance demands rigorous oversight, which can strain operational resources. Without sufficient investment in education and training, the shortage of qualified professionals may hinder service expansion and delay adoption in underserved areas.

Covid-19 Impact:

The COVID-19 pandemic had a multifaceted impact on the SPECT scanning services market. Initially, elective imaging procedures were postponed, and patient volumes declined due to lockdowns and infection control measures. However, the crisis also highlighted the importance of diagnostic imaging in managing cardiovascular and pulmonary complications associated with the virus. As healthcare systems adapted to the pandemic, SPECT services were re-prioritized for critical care and post-COVID evaluations.

The SPECT scanning devices segment is expected to be the largest during the forecast period

The SPECT scanning devices segment is expected to account for the largest market share during the forecast period due to their widespread clinical adoption and technological advancements. These systems are increasingly being equipped with multi-detector configurations and digital processing capabilities, enhancing image resolution and throughput. Their versatility in diagnosing a range of conditions from cardiac ischemia to neurodegenerative disorders makes them a cornerstone of functional imaging.

The coronary artery disease diagnosis segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the coronary artery disease diagnosis segment is predicted to witness the highest growth rate driven by the escalating burden of cardiovascular conditions worldwide. SPECT myocardial perfusion imaging is a well-established technique for assessing blood flow and detecting ischemic regions, offering critical insights into cardiac function. Innovations in radiotracers and imaging protocols are improving diagnostic precision and patient safety. As preventive cardiology gains momentum, SPECT is playing a vital role in risk stratification and monitoring therapeutic efficacy, especially in high-risk populations.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share attributed to its advanced healthcare infrastructure and high adoption of nuclear imaging technologies. The region benefits from a robust reimbursement framework, strong presence of leading imaging equipment manufacturers, and widespread availability of trained professionals. Additionally, ongoing research initiatives and clinical trials are fostering innovation in radiopharmaceuticals and imaging protocols.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR owing to rapid growth is driven by expanding healthcare infrastructure, increasing awareness of advanced diagnostic imaging, and rising prevalence of chronic diseases such as cardiovascular and neurological disorders in emerging economies like China and India. Additionally, government initiatives aimed at improving healthcare access, coupled with growing investments in medical technology and rising disposable incomes, are fueling the adoption of SPECT scanning services.

Key players in the market

Some of the key players in SPECT Scanning Services Market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Bracco Imaging, Curium Pharma, Cardinal Health Inc., Lantheus Medical Imaging, Digirad Corporation, Spectrum Dynamics Medical, Gamma Medica Inc., Guerbet, Neusoft Medical Systems, Toshiba International Corporation, Mediso Ltd. and Positron Corporation.

Key Developments:

In August 2025, Cardinal Health acquired Solaris Health, a leading urology MSO. The move supports specialty care expansion and aligns with strong Q4 earnings of $60.2B revenue.

In January 2025, Philips showcased AI-driven diagnostic and monitoring systems at Arab Health 2025. Highlights included the BlueSeal helium-free MRI and Spectral CT 7500 for advanced imaging.

In January 2025, Siemens Healthineers unveiled photon-counting CT and helium-free MRI at Arab Health 2025. The NAEOTOM Alpha and MAGNETOM Flow platforms aim to redefine precision imaging and sustainability.

Product Types Covered:

  • SPECT Scanning Devices
  • SPECT Scanning Services

Radioisotope Types Covered:

  • Technetium-99m (Tc-99m)
  • Gallium-67 (Ga-67)
  • Iodine-123 (I-123)
  • Thallium-201 (Th-201)
  • Radium-223 (Ra-223)
  • Other Radioisotope Types

Applications Covered:

  • Myocardial Perfusion Imaging
  • Coronary Artery Disease Diagnosis
  • Tumor Detection & Monitoring
  • Cancer Staging
  • Brain Disorders
  • Epilepsy Diagnosis
  • Other Applications

End Users Covered:

  • Diagnostic Imaging Centers
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Research & Academic Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global SPECT Scanning Services Market, By Product Type

  • 5.1 Introduction
  • 5.2 SPECT Scanning Devices
    • 5.2.1 Portable SPECT Systems
    • 5.2.2 Fixed/Standalone SPECT Systems
    • 5.2.3 SPECT/CT Hybrid Systems
  • 5.3 SPECT Scanning Services
    • 5.3.1 Diagnostic Imaging
    • 5.3.2 Therapeutic Monitoring
    • 5.3.3 Drug Development & Research Support

6 Global SPECT Scanning Services Market, By Radioisotope Type

  • 6.1 Introduction
  • 6.2 Technetium-99m (Tc-99m)
  • 6.3 Gallium-67 (Ga-67)
  • 6.4 Iodine-123 (I-123)
  • 6.5 Thallium-201 (Th-201)
  • 6.6 Radium-223 (Ra-223)
  • 6.7 Other Radioisotope Types

7 Global SPECT Scanning Services Market, By Application

  • 7.1 Introduction
  • 7.2 Myocardial Perfusion Imaging
  • 7.3 Coronary Artery Disease Diagnosis
  • 7.4 Tumor Detection & Monitoring
  • 7.5 Cancer Staging
  • 7.6 Brain Disorders
  • 7.7 Epilepsy Diagnosis
  • 7.8 Other Applications

8 Global SPECT Scanning Services Market, By End User

  • 8.1 Introduction
  • 8.2 Diagnostic Imaging Centers
  • 8.3 Hospitals
  • 8.4 Ambulatory Surgical Centers (ASCs)
  • 8.5 Research & Academic Institutes
  • 8.6 Other End Users

9 Global SPECT Scanning Services Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 GE Healthcare
  • 11.2 Siemens Healthineers
  • 11.3 Philips Healthcare
  • 11.4 Bracco Imaging
  • 11.5 Curium Pharma
  • 11.6 Cardinal Health Inc.
  • 11.7 Lantheus Medical Imaging
  • 11.8 Digirad Corporation
  • 11.9 Spectrum Dynamics Medical
  • 11.10 Gamma Medica Inc.
  • 11.11 Guerbet
  • 11.12 Neusoft Medical Systems
  • 11.13 Toshiba International Corporation
  • 11.14 Mediso Ltd.
  • 11.15 Positron Corporation

List of Tables

able 1 Global SPECT Scanning Services Market Outlook, By Region (2024-2032) ($MN)

  • Table 2 Global SPECT Scanning Services Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global SPECT Scanning Services Market Outlook, By SPECT Scanning Devices (2024-2032) ($MN)
  • Table 4 Global SPECT Scanning Services Market Outlook, By Portable SPECT Systems (2024-2032) ($MN)
  • Table 5 Global SPECT Scanning Services Market Outlook, By Fixed/Standalone SPECT Systems (2024-2032) ($MN)
  • Table 6 Global SPECT Scanning Services Market Outlook, By SPECT/CT Hybrid Systems (2024-2032) ($MN)
  • Table 7 Global SPECT Scanning Services Market Outlook, By SPECT Scanning Services (2024-2032) ($MN)
  • Table 8 Global SPECT Scanning Services Market Outlook, By Diagnostic Imaging (2024-2032) ($MN)
  • Table 9 Global SPECT Scanning Services Market Outlook, By Therapeutic Monitoring (2024-2032) ($MN)
  • Table 10 Global SPECT Scanning Services Market Outlook, By Drug Development & Research Support (2024-2032) ($MN)
  • Table 11 Global SPECT Scanning Services Market Outlook, By Radioisotope Type (2024-2032) ($MN)
  • Table 12 Global SPECT Scanning Services Market Outlook, By Technetium-99m (Tc-99m) (2024-2032) ($MN)
  • Table 13 Global SPECT Scanning Services Market Outlook, By Gallium-67 (Ga-67) (2024-2032) ($MN)
  • Table 14 Global SPECT Scanning Services Market Outlook, By Iodine-123 (I-123) (2024-2032) ($MN)
  • Table 15 Global SPECT Scanning Services Market Outlook, By Thallium-201 (Th-201) (2024-2032) ($MN)
  • Table 16 Global SPECT Scanning Services Market Outlook, By Radium-223 (Ra-223) (2024-2032) ($MN)
  • Table 17 Global SPECT Scanning Services Market Outlook, By Other Radioisotope Types (2024-2032) ($MN)
  • Table 18 Global SPECT Scanning Services Market Outlook, By Application (2024-2032) ($MN)
  • Table 19 Global SPECT Scanning Services Market Outlook, By Myocardial Perfusion Imaging (2024-2032) ($MN)
  • Table 20 Global SPECT Scanning Services Market Outlook, By Coronary Artery Disease Diagnosis (2024-2032) ($MN)
  • Table 21 Global SPECT Scanning Services Market Outlook, By Tumor Detection & Monitoring (2024-2032) ($MN)
  • Table 22 Global SPECT Scanning Services Market Outlook, By Cancer Staging (2024-2032) ($MN)
  • Table 23 Global SPECT Scanning Services Market Outlook, By Brain Disorders (2024-2032) ($MN)
  • Table 24 Global SPECT Scanning Services Market Outlook, By Epilepsy Diagnosis (2024-2032) ($MN)
  • Table 25 Global SPECT Scanning Services Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 26 Global SPECT Scanning Services Market Outlook, By End User (2024-2032) ($MN)
  • Table 27 Global SPECT Scanning Services Market Outlook, By Diagnostic Imaging Centers (2024-2032) ($MN)
  • Table 28 Global SPECT Scanning Services Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 29 Global SPECT Scanning Services Market Outlook, By Ambulatory Surgical Centers (ASCs) (2024-2032) ($MN)
  • Table 30 Global SPECT Scanning Services Market Outlook, By Research & Academic Institutes (2024-2032) ($MN)
  • Table 31 Global SPECT Scanning Services Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.